Sio Gene Therapies Inc 's

• SIOX's Stock Performance relative to its Competitors

X4 Pharmaceuticals Inc Share Performance +20.90% One Year

X4 Pharmaceuticals Inc Profile X4 Pharmaceuticals Inc is a biopharmaceutical company focused on the research and development of innovative treatments for rare diseases, particularly those involving the immune system and rare genetic disorders. Their business model revolves around identifying potential drug candidates, conducting preclinical and clinical trials, and ultimately bringing these therapies to market to improve patient outcomes. More about X4 Pharmaceuticals Inc's Market Share

Neurogene Inc Share Performance +25.38% This Quarter

Neurogene Inc Profile The company develops genetic medicines targeting rare neurological diseases and is currently in clinical stages. More about Neurogene Inc 's Market Share

Longeveron Inc Share Performance +820.78% This Quarter

Longeveron Inc Profile Longeveron Inc's business model involves the development and commercialization of regenerative medicine products using mesenchymal stem cells for various medical conditions. More about Longeveron Inc 's Market Share

International Stem Cell Corporation Share Performance +139.29% This Year

International Stem Cell Corporation Profile International Stem Cell Corporation is a biotechnology company that focuses on developing and commercializing stem cell-based therapeutic products. They utilize their unique technology to derive unlimited amounts of pluripotent stem cells, enabling them to create therapeutics for various medical conditions. More about International Stem Cell Corporation's Market Share

Immix Biopharma Inc Share Performance +125.78% This Year

Immix Biopharma Inc Profile ImmIx Biopharma Inc is a biotechnology company that focuses on developing novel therapeutics for the treatment of cancer. Their business model involves conducting extensive research and development to discover and optimize drug candidates, followed by preclinical and clinical testing to assess their safety and effectiveness. They aim to collaborate with pharmaceutical companies or seek licensing agreements to further develop and commercialize their biopharmaceutical products. More about Immix Biopharma Inc 's Market Share

Sources: Sio Gene Therapies Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 12, 2026 6:31 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Sio Gene Therapies Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.